VRML News and Press, Aspira Womens Health From 08/08/19

AUSTIN, Texas, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the second quarter ended June 30, 2019. “We are very pleased by the conti...

AUSTIN, Texas, July 31, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will report financial results for the three and six months ended June 30, 2019 on Thursday, August ...

-Highest Performing Early Stage Ovarian Cancer Risk Assessment Available Today- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced publication of a paper entitled: “Clinical Performance Comparison ...

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

Vermillion ( VRML +1.2% ) has priced public offering of 18.75M common stock at $0.80 per share. More news on: Vermillion, Inc., Healthcare stocks news, Read more ...

AUSTIN, Texas, June 26, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML) (“Vermillion”), a bioanalytical-based women’s health company focused on gynecologic disease, today announced the pricing of the previously announced underwritten public offering of 18,750,0...

AUSTIN, Texas, June 25, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML) (“Vermillion”), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it intends to offer shares of its common stock in an underwritten public of...

Vermillion ( VRML +15.1% ) says Blue Cross Blue Shield of Texas and Blue Cross Blue Shield of Arizona will begin offering preferred coverage of its OVA1 ovarian cancer risk assessment test. More news on: Vermillion, Inc., Healthcare stocks news, Stocks on the move, Read more ...

  Blue Cross Blue Shield of Texas and Blue Cross Blue Shield of Arizona now offering preferred coverage for  Vermillion’s ovarian cancer risk assessment test   Over 167M total lives now under coverage with an additional 6M lives under contract AUST...

Vermillion, Inc. (VRML) Q1 2019 Earnings Conference Call May 14, 2019 4:30 PM ET Company Participants Valerie Palmieri – President and Chief Executive Officer Bob Beechey – Chief Financial Officer Chris Goulart – Senior Vice President-Commercial Operations ...